Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
CellCept
Generic name / active ingredient
mycophenolate mofetil
Dosage-form class
Mycophenolate mofetil oral capsules, oral tablets and reconstituted oral suspension (as listed in the current U.S. label; neither different dosage forms nor mycophenolic-acid delayed-release tablets establish self-directed conversion or substitution).
Route
Oral
Record reviewed
2026-08-28

Copy from the pack in hand

Source-linked reading points

  • Check CELLCEPT, mycophenolate mofetil, dosage form, labelled amount or concentration per defined unit, pack and target market together. mg or mg/mL is a labelled amount or concentration in a defined unit, not a website instruction for anyone's number of tablets/capsules or suspension volume.
  • The label states that CELLCEPT oral forms and mycophenolic-acid delayed-release tablets have different absorption rates and should not be interchanged without supervision by a physician experienced in immunosuppressive therapy. Shared “mycophenolic” wording, nearby mg numbers, the same transplant context or a similar pack do not establish self-conversion, combining, alternation or substitution.
  • The label carries a boxed warning for embryo-fetal toxicity, malignancies and serious infections. Pregnancy or planning, infection, fever, exposure to chickenpox/shingles, vaccination, blood tests or any treatment change require item-by-item review of the actual pack and full medicine list with the transplant/specialist team or pharmacist; this site cannot decide whether to continue, pause or change treatment.
  • The label says CELLCEPT tablets should not be crushed and capsules should not be opened or crushed; reconstituted oral suspension should not be mixed with other liquids before use. Do not treat a question about splitting, opening or mixing as website permission in place of the actual label and professional advice. With powder contact involving skin, mucosa or eyes, or an acute serious concern, follow the current label first and contact local medical support.

Reviewed presentation examples — compare every field

  • Mycophenolate mofetil 250 mg per capsule (current U.S. label text identity; no exact package panel established)Current public label — oral capsule; no exact package panel established
  • Mycophenolate mofetil 500 mg per tablet (current U.S. label text identity; no exact package panel established)Current public label — oral tablet; no exact package panel established
  • Mycophenolate mofetil 200 mg per mL after reconstitution (current U.S. label text identity; no exact package panel established)Current public label — oral suspension after reconstitution; no exact package panel established

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-28
Source record
1 clickable primary-source entry point is listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image